Understand the source comparison
Peptides Vitamin D Immune Optimization: Research-Grade Compounds Comparison
Thymalin Stimulates thymic epithelial cells to secrete thymulin; promotes T-cell differentiation and Treg expansion Vitamin D upregulates thymulin receptors in progenitor T-cells by 35–50%; deficiency attenuates peptide response 5–10 mg reconstituted, administ
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Stimulates thymic epithelial cells to secrete thymulin; promotes T-cell differentiation and Treg expansion
- Vitamin D upregulates thymulin receptors in progenitor T-cells by 35–50%; deficiency attenuates peptide response
- 5–10 mg reconstituted, administered per research protocol
- Subcutaneous injection
- Thymalin is the most studied thymic peptide for immune restoration. Particularly effective when baseline 25(OH)D exceeds 40 ng/mL
- Vitamin D3 (Cholecalciferol)
- Binds VDR in thymic epithelial cells; upregulates peptide receptor transcription; inhibits NF-kB-driven inflammation
- N/A. Vitamin D is the foundational variable determining peptide receptor availability
- 4,000–6,000 IU daily until serum 25(OH)D reaches 40–60 ng/mL
- Oral or intramuscular
- Required baseline for peptide optimization. Receptor density cannot be maximized without adequate vitamin D status
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist; stimulates growth hormone and IGF-1 secretion; enhances thymic tissue regeneration
- Vitamin D increases GH receptor expression in thymic tissue; MK-677 efficacy improves when vitamin D status is optimized
- 10–25 mg daily in research models
- Oral
- Indirect immune support through thymic regeneration. Most effective in aging models where thymic involution has occurred
- KPV (Lys-Pro-Val)
- Inhibits NF-kB and reduces pro-inflammatory cytokines (IL-6, TNF-alpha); modulates gut-associated lymphoid tissue
- Vitamin D and KPV share overlapping anti-inflammatory pathways; combined use may produce synergistic NF-kB inhibition
- 500 mcg–2 mg per research protocol
- Subcutaneous or oral
- Effective for localized inflammatory modulation. Particularly relevant in gut-mediated immune dysfunction
- Vitamin D is the foundational variable. Thymic peptides cannot engage their receptors at full capacity without adequate vitamin D status. Researchers examining peptides vitamin D immune optimization measure baseline 25(OH)D before peptide introduction. Receptor availability is the rate-limiting step, not peptide dose.